NDC properties for NDC 9 0143-9005
NDC item 00143900501
NDC 9 | 0143-9005 |
---|---|
NDC 10 | 0143-9005-01 |
NDC Item | 00143900501 |
packaging | 1 VIAL in 1 CARTON (0143-9005-01) / 10 mL in 1 VIAL |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 598626 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-11-22 |
Marketing status | ACTIVE |
NDC item 00143972601
NDC 9 | 0143-9726 |
---|---|
NDC 10 | 0143-9726-01 |
NDC Item | 00143972601 |
packaging | 10 mL in 1 VIAL (0143-9726-01) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 627057 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
NDC item 00409656220
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-20 |
NDC Item | 00409656220 |
packaging | 1 VIAL in 1 CARTON (0409-6562-20) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
NDC item 00409656222
NDC 9 | 0409-6562 |
---|---|
NDC 10 | 0409-6562-22 |
NDC Item | 00409656222 |
packaging | 1 VIAL in 1 CARTON (0409-6562-22) / 10 mL in 1 VIAL |
ANDA | ANDA085635 |
DCSA | CIII |
FDA SPL set id | 500095 |
FDA SPL set id | 500287 |
Labeler | Hospira, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2018-01-17 |
Marketing status | ACTIVE |
NDC item 00574082010
NDC 9 | 0574-0820 |
---|---|
NDC 10 | 0574-0820-10 |
NDC Item | 00574082010 |
packaging | 1 VIAL, GLASS in 1 CARTON (0574-0820-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 768154 |
FDA SPL set id | 791051 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
NDC item 00574082710
NDC 9 | 0574-0827 |
---|---|
NDC 10 | 0574-0827-10 |
NDC Item | 00574082710 |
packaging | 1 VIAL, GLASS in 1 CARTON (0574-0827-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 838303 |
Labeler | Padagis US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | DROPPED |
NDC item 00591412879
NDC 9 | 0591-4128 |
---|---|
NDC 10 | 0591-4128-79 |
NDC Item | 00591412879 |
packaging | 10 mL in 1 VIAL (0591-4128-79) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 706717 |
Labeler | Actavis Pharma, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2025-05-31 |
Marketing effective time low | 2015-03-05 |
Marketing status | COMPLETED |
NDC item 47781091022
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-22 |
NDC Item | 47781091022 |
packaging | 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 816491 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
NDC item 47781091091
NDC 9 | 47781-910 |
---|---|
NDC 10 | 47781-910-91 |
NDC Item | 47781091091 |
packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (47781-910-91) / 10 mL in 1 VIAL, MULTI-DOSE (47781-910-22) |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 816491 |
Labeler | Alvogen Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
NDC item 50090414700
NDC 9 | 50090-4147 |
---|---|
NDC 10 | 50090-4147-0 |
NDC Item | 50090414700 |
packaging | 1 VIAL, GLASS in 1 CARTON (50090-4147-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 800537 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
NDC item 50090492000
NDC 9 | 50090-4920 |
---|---|
NDC 10 | 50090-4920-0 |
NDC Item | 50090492000 |
packaging | 1 VIAL, GLASS in 1 CARTON (50090-4920-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 800571 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
NDC item 50090492100
NDC 9 | 50090-4921 |
---|---|
NDC 10 | 50090-4921-0 |
NDC Item | 50090492100 |
packaging | 1 VIAL, GLASS in 1 CARTON (50090-4921-0) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 454880 |
Labeler | A-S Medication Solutions LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
NDC item 50090743500
NDC 9 | 50090-7435 |
---|---|
NDC 10 | 50090-7435-0 |
NDC Item | 50090743500 |
packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (50090-7435-0) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA206368 |
COLORTEXT | WHITE(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 828529 |
Labeler | A-S Medication Solutions |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
NDC item 52536062510
NDC 9 | 52536-625 |
---|---|
NDC 10 | 52536-625-10 |
NDC Item | 52536062510 |
packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (52536-625-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA206368 |
COLORTEXT | white(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 840857 |
Labeler | Wilshire Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
NDC item 55150027801
NDC 9 | 55150-278 |
---|---|
NDC 10 | 55150-278-01 |
NDC Item | 55150027801 |
packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-278-01) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA211817 |
DCSA | CIII |
FDA SPL set id | 739422 |
Labeler | Eugia US LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-10-20 |
Marketing status | ACTIVE |
NDC item 62756001640
NDC 9 | 62756-016 |
---|---|
NDC 10 | 62756-016-40 |
NDC Item | 62756001640 |
packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (62756-016-40) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA201720 |
DCSA | CIII |
FDA SPL set id | 581578 |
Labeler | Sun Pharmaceutical Industries, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2013-06-17 |
Marketing status | ACTIVE |
NDC item 63187064710
NDC 9 | 63187-647 |
---|---|
NDC 10 | 63187-647-10 |
NDC Item | 63187064710 |
packaging | 10 mL in 1 VIAL (63187-647-10) |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 425948 |
Labeler | Proficient Rx LP |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2012-05-01 |
Marketing status | ACTIVE |
NDC item 63629870501
NDC 9 | 63629-8705 |
---|---|
NDC 10 | 63629-8705-1 |
NDC Item | 63629870501 |
packaging | 1 VIAL, GLASS in 1 CARTON (63629-8705-1) / 1 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719441 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
NDC item 63629870601
NDC 9 | 63629-8706 |
---|---|
NDC 10 | 63629-8706-1 |
NDC Item | 63629870601 |
packaging | 1 VIAL, GLASS in 1 CARTON (63629-8706-1) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 719366 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
NDC item 69097053737
NDC 9 | 69097-537 |
---|---|
NDC 10 | 69097-537-37 |
NDC Item | 69097053737 |
packaging | 10 mL in 1 VIAL, GLASS (69097-537-37) |
ANDA | ANDA210362 |
COLORTEXT | WHITE("A clear colourless to pale yellow solution) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 729362 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-09-15 |
Marketing status | ACTIVE |
NDC item 69097080237
NDC 9 | 69097-802 |
---|---|
NDC 10 | 69097-802-37 |
NDC Item | 69097080237 |
packaging | 1 VIAL, GLASS in 1 CARTON (69097-802-37) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 764872 |
Labeler | Cipla USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
NDC item 70700029022
NDC 9 | 70700-290 |
---|---|
NDC 10 | 70700-290-22 |
NDC Item | 70700029022 |
packaging | 1 VIAL in 1 CARTON (70700-290-22) / 10 mL in 1 VIAL |
ANDA | ANDA215351 |
DCSA | CIII |
FDA SPL set id | 708164 |
Labeler | Xiromed LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2023-04-28 |
Marketing status | ACTIVE |
NDC item 71335247301
NDC 9 | 71335-2473 |
---|---|
NDC 10 | 71335-2473-1 |
NDC Item | 71335247301 |
packaging | 1 VIAL, GLASS in 1 CARTON (71335-2473-1) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 807801 |
Labeler | Bryant Ranch Prepack |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
NDC item 72833067800
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-00 |
NDC Item | 72833067800 |
packaging | 1 VIAL, MULTI-DOSE in 1 BOX (72833-678-00) / 30 mL in 1 VIAL, MULTI-DOSE (72833-678-30) |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
NDC item 72833067830
NDC 9 | 72833-678 |
---|---|
NDC 10 | 72833-678-30 |
NDC Item | 72833067830 |
packaging | 30 mL in 1 VIAL, MULTI-DOSE |
DCSA | CIII |
FDA SPL set id | 536274 |
Labeler | ASP Cares |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | UNAPPROVED DRUG OTHER |
Marketing effective time low | 2019-04-24 |
Marketing status | ACTIVE |
UNAPPROVED_DRUG_OTHER | N/A |
NDC item 76420006510
NDC 9 | 76420-065 |
---|---|
NDC 10 | 76420-065-10 |
NDC Item | 76420006510 |
packaging | 10 mL in 1 VIAL, MULTI-DOSE (76420-065-10) |
ANDA | ANDA206368 |
COLORTEXT | white(or creamy white) |
Color | C48325 __ |
DCSA | CIII |
FDA SPL set id | 661409 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-05-31 |
Marketing status | ACTIVE |
NDC item 76420064510
NDC 9 | 76420-645 |
---|---|
NDC 10 | 76420-645-10 |
NDC Item | 76420064510 |
packaging | 1 VIAL, GLASS in 1 CARTON (76420-645-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA040530 |
DCSA | CIII |
FDA SPL set id | 748385 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2007-12-21 |
Marketing status | ACTIVE |
NDC item 76420074110
NDC 9 | 76420-741 |
---|---|
NDC 10 | 76420-741-10 |
NDC Item | 76420074110 |
packaging | 1 VIAL, GLASS in 1 CARTON (76420-741-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 787870 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2014-05-01 |
Marketing status | ACTIVE |
NDC item 76420074610
NDC 9 | 76420-746 |
---|---|
NDC 10 | 76420-746-10 |
NDC Item | 76420074610 |
packaging | 1 VIAL, GLASS in 1 CARTON (76420-746-10) / 10 mL in 1 VIAL, GLASS |
ANDA | ANDA091244 |
DCSA | CIII |
FDA SPL set id | 791011 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2019-03-26 |
Marketing status | ACTIVE |
NDC item 76420075210
NDC 9 | 76420-752 |
---|---|
NDC 10 | 76420-752-10 |
NDC Item | 76420075210 |
packaging | 1 VIAL, MULTI-DOSE in 1 CARTON (76420-752-10) / 10 mL in 1 VIAL, MULTI-DOSE |
ANDA | ANDA207742 |
DCSA | CIII |
FDA SPL set id | 791057 |
Labeler | Asclemed USA, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-11-02 |
Marketing status | ACTIVE |
NDC item 76519121000
NDC 9 | 76519-1210 |
---|---|
NDC 10 | 76519-1210-0 |
NDC Item | 76519121000 |
packaging | 1 mL in 1 VIAL, MULTI-DOSE (76519-1210-0) |
ANDA | ANDA091244 |
DCSA | CIII |
Labeler | H.J. Harkins Co, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing status | ACTIVE |